Moderna (MRNA) News Today $27.60 -1.96 (-6.63%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$27.72 +0.13 (+0.45%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Moderna Dropping Today?Toggle Visibility of Why Is Moderna Dropping Today?Moderna, Inc. (NASDAQ: MRNA) stock is down today as strong Q2 results are offset by a trimmed 2025 outlook and cost-cutting measures. Positive Sentiment: Q2 beat estimates with EPS loss of $2.13 vs. $2.99 expected and $142 M revenue vs. $116 M consensus. MRNA Beats on Q2 Earnings & Sales Positive Sentiment: Spikevax Q2 sales topped expectations despite ongoing decline in demand. Spikevax Sales Beat Positive Sentiment: UK Court of Appeal upheld validity of EP’949 patent, finding Pfizer/BioNTech’s Comirnaty infringes it. Patent Win Positive Sentiment: Announced three FDA approvals and positive Phase 3 flu vaccine data, expanding pipeline prospects. Business Updates Neutral Sentiment: Unusually large options activity as investors bought 133,074 call options, up 61% from average. Neutral Sentiment: CEO Stéphane Bancel indicated no M&A plans but highlighted R&D partnership strategy. R&D Partnerships Negative Sentiment: Cuts 2025 revenue outlook by $300 M at high end to $1.5–2.2 B, citing U.K. vaccine delivery delays. Sales Forecast Cut Negative Sentiment: Plans to reduce headcount by approximately 10% (over 800 roles) as part of cost-cutting. Layoff Plan Negative Sentiment: Stock drifts lower as full-year outlook cut overshadows earnings beat. Why Moderna Stock Is Trading Lower Posted 1+ days agoAI Generated. May Contain Errors. MRNA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Banque Cantonale Vaudoise Acquires New Stake in Moderna, Inc. (NASDAQ:MRNA)August 3 at 5:15 AM | marketbeat.comModerna Sees Unusually High Options Volume (NASDAQ:MRNA)August 2 at 2:59 PM | marketbeat.comModerna (NASDAQ:MRNA) Shares Gap Down - Time to Sell?August 2 at 11:08 AM | marketbeat.comModerna is laying off 10% of its workforce. Does RFK Jr. have anything to do with it?August 2 at 10:18 AM | msn.comModerna, Inc. (NASDAQ:MRNA) Q2 2025 Earnings Call TranscriptAugust 2 at 10:18 AM | msn.comWealthquest Corp Takes $1.04 Million Position in Moderna, Inc. (NASDAQ:MRNA)August 2 at 5:47 AM | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Acquired by Federated Hermes Inc.August 2 at 5:13 AM | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Has $5.45 Million Position in Moderna, Inc. (NASDAQ:MRNA)August 2 at 5:01 AM | marketbeat.comPacer Advisors Inc. Cuts Stock Position in Moderna, Inc. (NASDAQ:MRNA)August 2 at 5:01 AM | marketbeat.comModerna cuts sales forecast on UK revenue delay, shares fallAugust 1 at 1:19 PM | reuters.comWhy Moderna (MRNA) Stock Is Trading Lower TodayAugust 1 at 1:19 PM | finance.yahoo.comModerna, Inc. (MRNA) Q2 2025 Earnings Call TranscriptAugust 1 at 12:04 PM | seekingalpha.comModerna, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 1 at 11:55 AM | seekingalpha.comModerna slashes full-year sales outlook, reduces headcountAugust 1 at 11:23 AM | proactiveinvestors.comModerna Stock Drops as Firm Cuts Revenue Outlook on UK Vaccine Deliveries DelayAugust 1 at 11:10 AM | investopedia.comModerna: Q2 Earnings SnapshotAugust 1 at 8:19 AM | sfgate.comModerna lowers top end of revenue guidance as vaccine group targets cost cutsAugust 1 at 8:19 AM | finance.yahoo.comModerna Logs Sales Beat Despite Declining Vaccine DemandAugust 1 at 8:19 AM | msn.comModerna Stock Dives After Earnings Report. What Has Wall Street Worried.August 1 at 8:19 AM | msn.comModerna drops after narrowing 2025 revenue outlookAugust 1 at 8:19 AM | msn.comModerna (NASDAQ:MRNA) Exceeds Q2 Expectations But Stock DropsAugust 1 at 8:19 AM | finance.yahoo.comModerna Stock Drops After Earnings Report. What Has Wall Street Worried.August 1 at 7:23 AM | barrons.comModerna quarterly sales beat Street estimates on COVID booster sales, cost cutsAugust 1 at 7:08 AM | reuters.comModerna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.August 1 at 7:03 AM | cnbc.comPfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent winAugust 1 at 5:59 AM | reuters.comModerna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallAugust 1 at 5:02 AM | benzinga.comPrivate Advisor Group LLC Sells 13,174 Shares of Moderna, Inc. (NASDAQ:MRNA)August 1 at 4:38 AM | marketbeat.comModerna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallAugust 1 at 4:37 AM | benzinga.comMore than 800 Moderna employees will lose their jobs this year as costs are slashedAugust 1 at 3:17 AM | msn.comModerna plans to slash 10% of workforce as COVID shot sales slowJuly 31 at 10:16 PM | msn.comModerna to lay off 10% of staff this yearJuly 31 at 5:12 PM | msn.comModerna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sinkJuly 31 at 5:12 PM | msn.com7MRNA : Moderna's Earnings: A PreviewJuly 31 at 5:12 PM | benzinga.comModerna braces for deep Q2 loss as vaccine demand wanesJuly 31 at 5:12 PM | msn.comModerna to cut more than 800 jobs this year as it burns through cashJuly 31 at 5:12 PM | msn.comModerna plans to lay off 10% of workforce to cut costsJuly 31 at 7:34 AM | reuters.comModerna to slash 10% of workforce as biotech cuts costs, Covid shot sales slowJuly 31 at 7:15 AM | cnbc.comPandemic darlings Moderna, BioNTech are now on two different pathsJuly 31 at 7:00 AM | cnbc.comModerna (MRNA) to Release Quarterly Earnings on FridayJuly 31 at 3:47 AM | americanbankingnews.comModerna Earnings: What To Look For From MRNAJuly 30, 2025 | msn.comLetko Brosseau & Associates Inc. Has $25.41 Million Stake in Moderna, Inc. (NASDAQ:MRNA)July 30, 2025 | marketbeat.comBryce Point Capital LLC Invests $801,000 in Moderna, Inc. (NASDAQ:MRNA)July 28, 2025 | marketbeat.comVictory Capital Management Inc. Lowers Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)July 28, 2025 | marketbeat.comBaillie Gifford & Co. Reduces Stock Position in Moderna, Inc. (NASDAQ:MRNA)July 26, 2025 | marketbeat.comDown 74% Over the Past Year, Is Moderna Stock a Buy?July 26, 2025 | fool.comModerna, Inc. (NASDAQ:MRNA) Receives Consensus Recommendation of "Hold" from AnalystsJuly 26, 2025 | marketbeat.comEU regulator backs Moderna's updated COVID vaccineJuly 25, 2025 | reuters.comUniversal Beteiligungs und Servicegesellschaft mbH Boosts Stake in Moderna, Inc. (NASDAQ:MRNA)July 25, 2025 | marketbeat.comModerna (MRNA) Expected to Announce Earnings on FridayJuly 25, 2025 | marketbeat.comKennedy's mRNA Moves Anger MAHA Allies; Winning Back NIH Grants; Start-Up Games HSAsJuly 24, 2025 | msn.com Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.220.46▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼4624▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRISPR Therapeutics News CureVac News Robinhood Markets News Novavax News Ocugen News Tesla News Johnson & Johnson News Merck & Co., Inc. News Pfizer News Takeda Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
